Cargando…

High Tenofovir Failure Rates in an Emerging, Non-B Subtype HIV Epidemic

BACKGROUND: The WHO-recommended regimen for antiretrovirals (ARVs) is tenofovir (TDF) + lamivudine/emtricitabine (3TC/FTC) + efavirenz (EFV), based on demonstrated superiority of TDF+FTC+EFV over zidovudine (AZT) +FTC+ EFV in clinical trials. However, there are reports of increasing TDF resistance i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salvana, Edsel Maurice, Schwem, Brian, Samonte, Genesis, Telan, Elizabeth, Tactacan-Abrenica, Rosario, Ching, Patrick, Mendoza, Kevin, Arevalo, Geraldine, Alejandria, Marissa, Leyritana, Katerina, Trinidad, Lyka, Penalosa, Christine, Lim, Jodor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631214/ http://dx.doi.org/10.1093/ofid/ofx163.1081

Ejemplares similares

2507. Transmitted and Acquired NNRTI Resistance in the Philippines: Are Newer Generation NNRTIs a Viable Option?
por: Theresa Dungca, Nina, et al.
Publicado: (2019)

1281. Emergence of a B/F1 HIV Recombinant in the Philippines: A Potentially New Circulating Recombinant Form
por: Schwem, Brian, et al.
Publicado: (2018)

1282. Detection of HIV Transmitted Drug Resistance by Next-Generation Sequencing in a CRF01_AE Predominant Epidemic
por: Salvana, Edsel Maurice, et al.
Publicado: (2018)

1541 The Changing Molecular Epidemiology of HIV in the Philippines: Major Shift from Subtype B to CRF01_AE
por: Schwem, Brian, et al.
Publicado: (2014)

361. Residual Lamivudine-Resistant Hepatitis B Virus Detected on Next-Generation Sequencing of Treatment-Experienced HIV Patients Failing Antiretrovirals
por: Schwem, Brian, et al.
Publicado: (2019)

1473 HIV in Pregnant Women in the Philippines: Revisiting Prospects for Universal Screening
por: Bartolome, Maria Jasmin Marinela, et al.
Publicado: (2014)

633. Nanopore Sequencing and In-house Bioinformatic Pipeline for Rapid and Accurate Detection of NRTI, NNRTI, PI, and INSTI Drug Resistance Mutations
por: Salvaña, Edsel Maurice, et al.
Publicado: (2023)

Depression, Nutrition, and Adherence to Antiretroviral Therapy in Men Who Have Sex With Men in Manila, Philippines
por: Elsayed, Hend, et al.
Publicado: (2021)

Interactive Mobile Phone HIV Adherence Support for Men Who Have Sex With Men in the Philippines Connect for Life Study: Mixed Methods Approach to Intervention Development and Pilot Testing
por: O'Connor, Cara, et al.
Publicado: (2022)

Delivering an mHealth Adherence Support Intervention for Patients With HIV: Mixed Methods Process Evaluation of the Philippines Connect for Life Study
por: O'Connor, Cara, et al.
Publicado: (2022)

Metabolic Profile of People Living with HIV in a Treatment Hub in Manila, Philippines: A Pre- and Post-Antiretroviral Analysis*
por: Francisco, Christian, et al.
Publicado: (2022)

Plasma Levels of a Cleaved Form of Galectin-9 Are the Most Sensitive Biomarkers of Acquired Immune Deficiency Syndrome and Tuberculosis Coinfection
por: Padilla, Shirley T., et al.
Publicado: (2020)

A descriptive retrospective study on HIV care cascade in a tertiary hospital in the Philippines
por: Nepomuceno, Marisse, et al.
Publicado: (2023)

Intrinsic Replication Competences of HIV Strains After Zidovudine/Lamivudine/Nevirapine Treatment in the Philippines
por: Kageyama, Seiji, et al.
Publicado: (2019)

Assessment of a multiplex PCR and Nanopore-based method for dengue virus sequencing in Indonesia
por: Stubbs, Samuel C. B., et al.
Publicado: (2020)

Safeguarding equitable HIV service delivery at the health facility-level in a resource-limited setting during the pandemic
por: Tactacan-Abrenica, Rosario Jessica, et al.
Publicado: (2022)

HIV-1 Subtype C, Tenofovir, and the Relationship With Treatment Failure and Drug Resistance
por: Günthard, Huldrych F., et al.
Publicado: (2016)

372. Prevalence of Urethral, Rectal, and Pharyngeal Gonorrhea and Chlamydia among Newly Diagnosed Filipino HIV Patients
por: Li, Kingbherly L, et al.
Publicado: (2019)

Target product profile for a dengue pre-vaccination screening test
por: Fongwen, Noah, et al.
Publicado: (2021)

A Review and Clinical Understanding of Tenofovir: Tenofovir Disoproxil Fumarate versus Tenofovir Alafenamide
por: Wassner, Chanie, et al.
Publicado: (2020)

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
por: Kawuma, Aida N., et al.
Publicado: (2023)

Ganciclovir–tenofovir interaction leading to tenofovir-induced nephrotoxicity
por: Soanker, Radhika, et al.
Publicado: (2014)

Population pharmacokinetics of tenofovir and tenofovir‐diphosphate in healthy women
por: Burns, Rebecca N., et al.
Publicado: (2015)

Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings
por: Thurman, Andrea Ries, et al.
Publicado: (2019)

Is DOTS-Plus a Feasible and Cost-Effective Strategy?
por: Garner, Paul, et al.
Publicado: (2006)

Mid-upper arm circumference predicts death in adult patients admitted to a TB ward in the Philippines: A prospective cohort study
por: Lee, Nathaniel, et al.
Publicado: (2019)

351. It Is Not Always Tuberculosis: Cytomegalovirus Polyradiculopathy and Encephalitis in Two Filipino Men With Advanced HIV Infection
por: Valencia, Jose Carlo, et al.
Publicado: (2018)

Urine Assay to Measure Tenofovir Concentrations in Patients Taking Tenofovir Alafenamide
por: Lalley-Chareczko, Linden, et al.
Publicado: (2020)

Review of tenofovir-emtricitabine
por: Masho, Saba Woldemichael, et al.
Publicado: (2007)

Chemoenzymatic Synthesis of Tenofovir
por: Zdun, Beata, et al.
Publicado: (2023)

Efficacy of topical tenofovir against transmission of a tenofovir-resistant SHIV in macaques
por: Dobard, Charles W, et al.
Publicado: (2015)

Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide
por: Funderburg, Nicholas T., et al.
Publicado: (2016)

Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide
por: Michienzi, Sarah M, et al.
Publicado: (2021)

Recovery of Tenofovir-induced Nephrotoxicity following Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Human Immunodeficiency Virus-Positive Patients
por: Seo, Jun-Won, et al.
Publicado: (2020)

Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing
por: Johnson, Kelly A, et al.
Publicado: (2021)

No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom
por: White, Ellen, et al.
Publicado: (2016)

Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?
por: Hill, Andrew, et al.
Publicado: (2018)

Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity
por: Walti, Laura N, et al.
Publicado: (2018)

Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate
por: Huhn, Gregory D, et al.
Publicado: (2019)

Comparative pharmacokinetics between tenofovir disoproxil phosphate and tenofovir disoproxil fumarate in healthy subjects
por: Lee, Sangmi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iv0oil7vtomefobn6el89kup0q